AAN 2022
Ganaxolone: A Treatment for Major Motor Seizures in CDKL5 Deficiency Disorder
In a global, phase 3 trial, researchers evaluated the efficacy of ganaxolone as an adjunctive treatment compared to placebo for major motor seizures in patients with CDKL5 deficiency disorder.